PC-002 (Sepantronium Bromide) Enhances the Antitumor Efficacy of Anti-CD20 Antibody By CD20 Upregulation

被引：0
|
作者：
Jiang, Vernon [1 ]
Li, Xiang [1 ]
He, Na [1 ]
Lv, Yan [1 ]
Wang, Haiyue [1 ]
Zhang, Ming [1 ]
Zhai, Heiyan [1 ]
Yang, Zhen [1 ]
Yang, Yi [1 ]
Guo, Dagang [1 ]
Cao, Zhixiang [1 ]
Chen, Yiyou [1 ]
机构：
[1] Cothera Biosci, San Mateo, CA USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-209648
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5822 / 5823
页数：2
相关论文
共 50 条
  • [31] The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders
    Musto, Pellegrino
    D'Auria, Fiorella
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (05) : 551 - 557
  • [32] Recurrent monomorphic epitheliotropic intestinal T-cell lymphoma with aberrant CD20 expression: An implication for anti-CD20 (rituximab) antibody therapy?
    Liao, Pi-Han
    Chou, Shih-Cheng
    Huang, Wan-Ting
    Su, Ying-Zhen
    Wang, Ming-Chung
    Chuang, Shih-Sung
    PATHOLOGY INTERNATIONAL, 2018, 68 (12) : 712 - 714
  • [33] Efficacy of monoclonal antibody anti CD20 in extranodal minimal residual disease eradication
    Petrilli, M. P.
    Cinieri, S.
    Giordano, G.
    Ruggiero, T.
    Cavotta, S.
    Capussela, E.
    Ferrandina, C.
    Gasbarrino, C.
    Fraticelli, V.
    Monaco, M.
    Storti, S.
    ANNALS OF ONCOLOGY, 2005, 16 : 60 - 60
  • [34] Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis
    Foran, JM
    Norton, AJ
    Micallef, INM
    Taussig, DC
    Amess, JAL
    Rohatiner, AZS
    Lister, TA
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) : 881 - 883
  • [35] Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity
    Winiarska, Magdalena
    Nowis, Dominika
    Bil, Jacek
    Glodkowska-Mrowka, Eliza
    Muchowicz, Angelika
    Wanczyk, Malgorzata
    Bojarczuk, Kamil
    Dwojak, Michal
    Firczuk, Malgorzata
    Wilczek, Ewa
    Wachowska, Malgorzata
    Roszczenko, Katarzyna
    Miaczynska, Marta
    Chlebowska, Justyna
    Basak, Grzegorz Wladyslaw
    Golab, Jakub
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (38) : 31983 - 31993
  • [36] Obinutuzumab: a new class of anti-CD20 monoclonal antibody
    Gagez, Anne-Laure
    Cartron, Guillaume
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (05) : 484 - 491
  • [37] Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus
    Arin, MJ
    Engert, A
    Krieg, T
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) : 620 - 625
  • [38] Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection
    Beers, Stephen A.
    French, Ruth R.
    Chan, H. T. Claude
    Lim, Sean H.
    Jarrett, Timothy C.
    Vidal, Regina Mora
    Wijayaweera, Sahan S.
    Dixon, Sandra V.
    Kim, Hyungjin
    Cox, Kerry L.
    Kerr, Jonathan P.
    Johnston, David A.
    Johnson, Peter W. M.
    Verbeek, J. Sjef
    Glennie, Martin J.
    Cragg, Mark S.
    BLOOD, 2010, 115 (25) : 5191 - 5201
  • [39] The effect of anti-CD20 antibody treatment in cynomolgus monkeys
    Park, Hyojun
    Kwon, Yeongbeen
    Lee, Kyo Won
    Park, Jae Berm
    Kim, Sung Joo
    Kim, Kaabsoo
    Lee, Sanghoon
    Lee, Suk Koo
    XENOTRANSPLANTATION, 2015, 22 : S119 - S119
  • [40] VELTUZUMAB Humanized Anti-CD20 Monoclonal Antibody Oncolytic
    Bhat, S. A.
    Czuczman, M. S.
    DRUGS OF THE FUTURE, 2011, 36 (07) : 519 - 526
12345